194 related articles for article (PubMed ID: 25644518)
1. In vivo evaluation of the inflammatory response and IL-6 immunoexpression promoted by Biodentine and MTA Angelus.
da Fonseca TS; da Silva GF; Tanomaru-Filho M; Sasso-Cerri E; Guerreiro-Tanomaru JM; Cerri PS
Int Endod J; 2016 Feb; 49(2):145-53. PubMed ID: 25644518
[TBL] [Abstract][Full Text] [Related]
2. Mast cells and immunoexpression of FGF-1 and Ki-67 in rat subcutaneous tissue following the implantation of Biodentine and MTA Angelus.
da Fonseca TS; Silva GF; Guerreiro-Tanomaru JM; Sasso-Cerri E; Tanomaru-Filho M; Cerri PS
Int Endod J; 2019 Jan; 52(1):54-67. PubMed ID: 29975794
[TBL] [Abstract][Full Text] [Related]
3. Participation of fibroblast growth factor-1 and interleukin-10 in connective tissue repair following subcutaneous implantation of bioceramic materials in rats.
Delfino MM; Jampani JLA; Lopes CS; Guerreiro-Tanomaru JM; Tanomaru-Filho M; Sasso-Cerri E; Cerri PS
Int Endod J; 2023 Mar; 56(3):385-401. PubMed ID: 36353742
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility evaluation of biodentine in subcutaneous tissue of rats.
Mori GG; Teixeira LM; de Oliveira DL; Jacomini LM; da Silva SR
J Endod; 2014 Sep; 40(9):1485-8. PubMed ID: 25146039
[TBL] [Abstract][Full Text] [Related]
5. Hypertension affects the biocompatibility and biomineralization of MTA, High-plasticity MTA, and Biodentine®.
Cosme-Silva L; Dal-Fabbro R; Gonçalves LO; Prado ASD; Plazza FA; Viola NV; Cintra LTA; Gomes Filho JE
Braz Oral Res; 2019 Jul; 33():e060. PubMed ID: 31365705
[TBL] [Abstract][Full Text] [Related]
6. Reduced interleukin-6 immunoexpression and birefringent collagen formation indicate that MTA Plus and MTA Fillapex are biocompatible.
Saraiva JA; da Fonseca TS; da Silva GF; Sasso-Cerri E; Guerreiro-Tanomaru JM; Tanomaru-Filho M; Cerri PS
Biomed Mater; 2018 Feb; 13(3):035002. PubMed ID: 29242419
[TBL] [Abstract][Full Text] [Related]
7. Biodentine and MTA modulate immunoinflammatory response favoring bone formation in sealing of furcation perforations in rat molars.
da Fonseca TS; Silva GF; Guerreiro-Tanomaru JM; Delfino MM; Sasso-Cerri E; Tanomaru-Filho M; Cerri PS
Clin Oral Investig; 2019 Mar; 23(3):1237-1252. PubMed ID: 29982967
[TBL] [Abstract][Full Text] [Related]
8. Biocompatibility and bioactive potential of NeoPUTTY calcium silicate-based cement: An in vivo study in rats.
Silva ECA; Pradelli JA; da Silva GF; Cerri PS; Tanomaru-Filho M; Guerreiro-Tanomaru JM
Int Endod J; 2024 Jun; 57(6):713-726. PubMed ID: 38467586
[TBL] [Abstract][Full Text] [Related]
9. Biocompatibility of mineral trioxide aggregate flow and biodentine.
Mondelli JAS; Hoshino RA; Weckwerth PH; Cerri PS; Leonardo RT; Guerreiro-Tanomaru JM; Tanomaru-Filho M; da Silva GF
Int Endod J; 2019 Feb; 52(2):193-200. PubMed ID: 30035812
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility and biomineralization assessment of mineral trioxide aggregate flow.
Bueno CRE; Vasques AMV; Cury MTS; Sivieri-Araújo G; Jacinto RC; Gomes-Filho JE; Cintra LTA; Dezan-Júnior E
Clin Oral Investig; 2019 Jan; 23(1):169-177. PubMed ID: 29572687
[TBL] [Abstract][Full Text] [Related]
11. Bioactive potential of Bio-C Pulpo is evidenced by presence of birefringent calcite and osteocalcin immunoexpression in the rat subcutaneous tissue.
Queiroz MB; Inada RNH; Lopes CS; Guerreiro-Tanomaru JM; Sasso-Cerri E; Tanomaru-Filho M; Cerri PS
J Biomed Mater Res B Appl Biomater; 2022 Oct; 110(10):2369-2380. PubMed ID: 35583398
[TBL] [Abstract][Full Text] [Related]
12. Tissue reactions to a new mineral trioxide aggregate-containing endodontic sealer.
Tavares CO; Böttcher DE; Assmann E; Kopper PM; de Figueiredo JA; Grecca FS; Scarparo RK
J Endod; 2013 May; 39(5):653-7. PubMed ID: 23611385
[TBL] [Abstract][Full Text] [Related]
13. Influence of diabetes mellitus on tissue response to MTA and its ability to stimulate mineralization.
Gomes-Filho JE; de Azevedo Queiroz ÍO; Watanabe S; da Silva Santos LM; Lodi CS; Okamoto R; Ervolino E; Dezan E; Cintra LT
Dent Traumatol; 2015 Feb; 31(1):67-72. PubMed ID: 25264083
[TBL] [Abstract][Full Text] [Related]
14. Reaction of rat subcutaneous tissue to mineral trioxide aggregate and Portland cement: a secondary level biocompatibility test.
Karanth P; Manjunath MK; ; Kuriakose ES
J Indian Soc Pedod Prev Dent; 2013; 31(2):74-81. PubMed ID: 23886716
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity, Biocompatibility, and Biomineralization of the New High-plasticity MTA Material.
Cintra LTA; Benetti F; de Azevedo Queiroz ÍO; de Araújo Lopes JM; Penha de Oliveira SH; Sivieri Araújo G; Gomes-Filho JE
J Endod; 2017 May; 43(5):774-778. PubMed ID: 28320539
[TBL] [Abstract][Full Text] [Related]
16. Tissue Response and Immunoexpression of Interleukin 6 Promoted by Tricalcium Silicate-based Repair Materials after Subcutaneous Implantation in Rats.
Andrade AS; Silva GF; Camilleri J; Cerri ES; Guerreiro-Tanomaru JM; Cerri PS; Tanomaru-Filho M
J Endod; 2018 Mar; 44(3):458-463. PubMed ID: 29398089
[TBL] [Abstract][Full Text] [Related]
17. Zirconium oxide and niobium oxide used as radiopacifiers in a calcium silicate-based material stimulate fibroblast proliferation and collagen formation.
Silva GF; Guerreiro-Tanomaru JM; da Fonseca TS; Bernardi MIB; Sasso-Cerri E; Tanomaru-Filho M; Cerri PS
Int Endod J; 2017 Dec; 50 Suppl 2():e95-e108. PubMed ID: 28470859
[TBL] [Abstract][Full Text] [Related]
18. Reactions of connective tissue to amalgam, intermediate restorative material, mineral trioxide aggregate, and mineral trioxide aggregate mixed with chlorhexidine.
Sumer M; Muglali M; Bodrumlu E; Guvenc T
J Endod; 2006 Nov; 32(11):1094-6. PubMed ID: 17055915
[TBL] [Abstract][Full Text] [Related]
19. Biocompatibility and bioactive potential of an experimental tricalcium silicate-based cement in comparison with Bio-C repair and MTA Repair HP materials.
Queiroz MB; Inada RNH; Jampani JLA; Guerreiro-Tanomaru JM; Sasso-Cerri E; Tanomaru-Filho M; Cerri PS
Int Endod J; 2023 Feb; 56(2):259-277. PubMed ID: 36314136
[TBL] [Abstract][Full Text] [Related]
20. Biocompatibility of new nanostructural materials based on active silicate systems and hydroxyapatite: in vitro and in vivo study.
Petrović V; Opačić-Galić V; Živković S; Nikolić B; Danilović V; Miletić V; Jokanović V; Mitić-Ćulafić D
Int Endod J; 2015 Oct; 48(10):966-75. PubMed ID: 25288256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
